AU6984698A - Treatment for insulin dependent diabetes - Google Patents

Treatment for insulin dependent diabetes

Info

Publication number
AU6984698A
AU6984698A AU69846/98A AU6984698A AU6984698A AU 6984698 A AU6984698 A AU 6984698A AU 69846/98 A AU69846/98 A AU 69846/98A AU 6984698 A AU6984698 A AU 6984698A AU 6984698 A AU6984698 A AU 6984698A
Authority
AU
Australia
Prior art keywords
treatment
dependent diabetes
insulin dependent
insulin
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU69846/98A
Other versions
AU727187B2 (en
Inventor
Linda C Burkly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen MA Inc
Original Assignee
Biogen Idec Inc
Biogen Idec MA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU62379/94A external-priority patent/AU687790B2/en
Application filed by Biogen Idec Inc, Biogen Idec MA Inc filed Critical Biogen Idec Inc
Priority to AU69846/98A priority Critical patent/AU727187B2/en
Publication of AU6984698A publication Critical patent/AU6984698A/en
Application granted granted Critical
Publication of AU727187B2 publication Critical patent/AU727187B2/en
Assigned to BIOGEN IDEC MA INC. reassignment BIOGEN IDEC MA INC. Request to Amend Deed and Register Assignors: BIOGEN, INC.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70542—CD106
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2842—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU69846/98A 1993-02-09 1998-06-02 Treatment for insulin dependent diabetes Ceased AU727187B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU69846/98A AU727187B2 (en) 1993-02-09 1998-06-02 Treatment for insulin dependent diabetes

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US029330 1993-02-09
AU62379/94A AU687790B2 (en) 1993-02-09 1994-02-09 Treatment for insulin dependent diabetes
AU69846/98A AU727187B2 (en) 1993-02-09 1998-06-02 Treatment for insulin dependent diabetes

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU62379/94A Division AU687790B2 (en) 1993-02-09 1994-02-09 Treatment for insulin dependent diabetes

Publications (2)

Publication Number Publication Date
AU6984698A true AU6984698A (en) 1998-07-23
AU727187B2 AU727187B2 (en) 2000-12-07

Family

ID=3747304

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69846/98A Ceased AU727187B2 (en) 1993-02-09 1998-06-02 Treatment for insulin dependent diabetes

Country Status (1)

Country Link
AU (1) AU727187B2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008823A1 (en) * 1991-11-06 1993-05-13 Tanabe Seiyaku Co., Ltd. Guanidinyl and related cell adhesion modulation compounds
DK0626861T4 (en) * 1992-01-13 2004-08-16 Biogen Inc Treatment of asthma.
ATE151642T1 (en) * 1992-02-12 1997-05-15 Biogen Inc TREATMENT FOR INFLAMMATORY DISEASE OF THE INTESTINAL

Also Published As

Publication number Publication date
AU727187B2 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
AU696232B2 (en) Syringe
AU6521394A (en) Syringe apparatus
AU8163394A (en) Treatment of diabetes by administration of myo-inositol
AU7085594A (en) Syringe
AU6479596A (en) Methods for treating diabetes
AU7170094A (en) Improved electro-optical sensor for spectrophotometric medical devices
AU2263197A (en) Diabetes therapy
AU5610494A (en) Shielded syringe
EP0755690A3 (en) Hypodermic cannula
AU8096994A (en) Safety syringe
AU6097794A (en) Method of treating diabetes mellitus
AU6151794A (en) Implantable glucose sensor
AU6425496A (en) Treatment for juvenile diabetes
EP0688570A3 (en) Insulin syringe
AU3236895A (en) Aspb1 insulin analogs
AU3989397A (en) Syringe assembly
AU5782194A (en) Single use hypodermic safety syringe
AU6160594A (en) Diabetes prevention and treatment
AU4219793A (en) Syringe
AU3730093A (en) Methods of treating diabetes
AU7672094A (en) Single-use syringe
AU7644194A (en) Diagnosis of insulin-dependent diabetes
AU6998196A (en) Medicinal composition for diabetes
AU6314496A (en) Insulin
AU7701794A (en) Safety syringe

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)